Chapman University

Chapman University Digital Commons
Pharmacy Faculty Articles and Research

School of Pharmacy

2011

A Comparison of Pharmacist Travel-Health
Specialists' versus Primary Care Providers'
Recommendations for Travel-Related Medications,
Vaccinations, and Patient Compliance in a College
Health Setting
Melissa J. Durham
University of Southern California

Jeffery A. Goad
Chapman University, goad@chapman.edu

Lawrence S. Neinstein
University Park Health Center

Mimi Lou
University of Southern California

Follow this and additional works at: http://digitalcommons.chapman.edu/pharmacy_articles
Part of the Bacterial Infections and Mycoses Commons, Pharmaceutical Preparations Commons,
Pharmacy and Pharmaceutical Sciences Commons, Therapeutics Commons, and the Virus Diseases
Commons
Recommended Citation
Durham MJ, Goad JA, Neinstein LS, Lou M. A Comparison of Pharmacist Travel-Health Specialists' versus Primary Care Providers'
Recommendations for Travel-Related Medications, Vaccinations, and Patient Compliance in a College Health Setting. Journal of Travel
Medicine 2011;18:20-5.
DOI:10.1111/j.1708-8305.2010.00470.x

This Article is brought to you for free and open access by the School of Pharmacy at Chapman University Digital Commons. It has been accepted for
inclusion in Pharmacy Faculty Articles and Research by an authorized administrator of Chapman University Digital Commons. For more information,
please contact laughtin@chapman.edu.

A Comparison of Pharmacist Travel-Health Specialists' versus Primary
Care Providers' Recommendations for Travel-Related Medications,
Vaccinations, and Patient Compliance in a College Health Setting
Comments

This is the accepted version of the following article:
Durham MJ, Goad JA, Neinstein LS, Lou M. A Comparison of Pharmacist Travel-Health Specialists' versus
Primary Care Providers' Recommendations for Travel-Related Medications, Vaccinations, and Patient
Compliance in a College Health Setting. Journal of Travel Medicine 2011;18:20-5
which has been published in final form at DOI: 10.1111/j.1708-8305.2010.00470.x.
Copyright

Wiley

This article is available at Chapman University Digital Commons: http://digitalcommons.chapman.edu/pharmacy_articles/5

1
A Comparison of Pharmacist Travel-health Specialists’ vs. Primary Care Providers’
Recommendations for Travel-related Medications, Vaccinations and Patient Compliance in a
College Health Setting
Melissa J. Durham, Pharm.D.
Lecturer in Clinical Pharmacy
University of Southern California School of Pharmacy
Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy
Los Angeles, CA
Jeffery A. Goad, Pharm.D.
Associate Professor of Clinical Pharmacy
University of Southern California School of Pharmacy
Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy
Los Angeles, CA
Lawrence S. Neinstein, MD
Professor, Pediatrics and Medicine
Executive Director, University Park Health Center
Senior Associate Dean of Student Affairs
Division Chief of College Health
University of Southern California Keck School of Medicine
Los Angeles, CA
Mimi Lou, MS
Project Manager
University of Southern California School of Pharmacy
Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy
Abstract presented at:
11th Conference of the International Society of Travel Medicine
Budapest, Hungary
May 24-28, 2009
Correspondence:
Melissa J. Durham, Pharm.D.
University of Southern California School of Pharmacy
1985 Zonal Avenue
Los Angeles, CA 90033
mdurham@usc.edu

2
Abstract
Background: The need for skilled pre-travel health practitioners increases as the number of
travelers at risk for travel-related illness rises. Few publications describe the role of pharmacists
as travel medicine clinicians. Pre-travel medication and vaccination recommendations and
receipt were compared between primary care providers without special training and clinical
pharmacists specializing in pre-travel health.
Methods: This was a retrospective chart review comparison of patients seen for pre-travel health
services in a pharmacist-run travel clinic (PTC) and by primary care providers (PCP) in 2007 at a
university student health center. Vaccine and medication recommendations were assessed for
consistency with national and international guidelines. Medical and pharmacy records were
queried to determine receipt of vaccines and medications.
Results: The 341 patients seen in PTC were more often recommended antibiotics for travelers’
diarrhea when indicated (96% vs. 50%, P < 0.0001) than the 172 seen by the PCPs and were also
more likely to receive their medication (75% vs. 63%, P = 0.04). Those seen by a PCP were
more frequently prescribed antibiotics for travelers’ diarrhea that were not consistent with
guidelines (not ordered when indicated 49% vs 6%, P < 0.0001 and ordered when not indicated
21% vs. 3%, P < 0.0001). Patients seen in the PTC were more often prescribed antimalarials
when indicated (98% vs. 81%, P < 0.0001), and those seen by a PCP were more frequently
prescribed antimalarials that were not consistent with guidelines (not ordered when indicated
15% vs 1%, P < 0.0001 and ordered when not indicated 19% vs. 2%, P < 0.0001). Patients seen
in the PTC were ordered more vaccines per patient when indicated (mean = 2.77 vs 2.31, P =
0.0012), and were also more likely to receive more vaccines when ordered (mean = 2.38 vs. 1.95,
P = 0.0039). The PCPs recommended more vaccines that were not consistent with guidelines per
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patient (not ordered when indicated: mean = 0.78 vs 0.12, P < 0.0001, ordered when not
indicated: mean 0.18 vs. 0.025, P < 0.0001).
Conclusions: A pharmacist-run pre-travel health clinic can provide consistent evidence-based
care and improve patient compliance compared to primary care providers without special
training. Pre-travel health is a dynamic and specialized field that requires adequate time,
resources, and expertise to deliver the best possible care.
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Background
Over the past few decades, the number of international tourists has grown from 457
million in 1990 to 880 million in 2009, and is estimated to reach 1.6 billion by 2020, with an
increasing proportion visiting the developing world. 1 Approximately 8 percent of travelers to the
developing world will require medical care during or after travel 2, most often for vaccine
preventable diseases and/or illnesses preventable by chemoprophylaxis and behavioral
measures.3-4 With the rapidly increasing number of travelers at high risk for travel-related illness,
there is an increased need for highly skilled travel medicine practitioners.
Despite common misperceptions, a thorough pre-travel consultation encompasses much
more than administration of vaccines. It is a comprehensive session that includes risk assessment
of travelers on their personal risk for travel-related illnesses; recommendation of nonprescription products and travel-related equipment; counseling on behavioral measures such as
basic food/water and insect precautions; prescription medications; administration of routine,
recommended, and required vaccinations; provision of written educational materials, and
counseling on personal safety and security.5-11 Unfortunately, not all travelers seek or receive this
type of comprehensive consultation prior to departure, as a result there is a significant lack of
knowledge and perception of risk regarding travel-related health issues among travelers
themselves.12-16
A 2003 New York airport survey serves as an example. In this study most travelers
surveyed were going to places where Hepatitis A was a risk, but only 14% had received the
vaccine. Furthermore, 27% of those who were going to high risk malaria regions thought they
were not at risk, and only 46% had antimalarials with them. Of the travelers who had
antimalarials, 42 % were carrying the medication chloroquine to areas with chloroquine-resistant
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plasmodium falciparum. 14 Recently, the CDC reported that there were 508 U.S. civilians who
acquired malaria abroad and for those whom chemoprophylaxis information was known (n=480),
71% reported they did not take a chemoprophylactic regimen recommended by the CDC. 17
While there is a deficiency in knowledge and compliance with recommendations among
travelers, there is also a need for improvement in education and training among health care
providers. 14-15, 18-23 Travel medicine is a dynamic specialty that necessitates advanced education
and training, as well as keeping up-to-date with current geographic risks. 11, 24 Primary care
providers are frequently called upon to provide pre-travel advice and recommendations, but may
lack sufficient knowledge, training, and time to adequately provide such services. 13, 18, 21-22 In
recent years, organizations such as the International Society of Travel Medicine and the
American Society of Tropical Medicine and Hygiene have taken major steps to further education
and training among health care providers and to advance travel medicine as a growing
specialty.24
There are very few publications describing the role of pharmacists in travel medicine.
Descriptive studies of clinical pharmacy travel medicine services exist, 25-27 and the few studies
that have evaluated the quality of travel recommendations of pharmacists have focused on the
community pharmacy setting. 28-31 To our knowledge, there are no published studies evaluating
the pre-travel health care of primary care providers in a student health setting and no studies
comparing the quality of the pre-travel recommendations of primary care providers without
special training versus clinical pharmacists who specialize in pre-travel health.
The setting for this study is a student health center at a major university. The clinical
pharmacists at the study setting operate a pre-travel health clinic at the Student Health Center,
which serves roughly 30,000 students, and have prescriptive authority for vaccines and
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medications under physician protocol. The objectives of this study are to compare the
recommendations for travel-related medications and vaccinations of the primary care providers
and the pharmacists specializing in pre-travel health, and also compare medication and
vaccination compliance between the two groups.
Methods
This was a retrospective comparison of all patients seen by a clinical pharmacist in a
pharmacist-run travel clinic (PTC) or by a primary care provider (PCP) for international travel
over a 1 year period in 2007 at a university student health center. The PCPs included physicians,
physician assistants and nurse practitioners. Data was obtained from an internal quality
assurance study and included information regarding itinerary, pediatric and adult vaccination
history, medical history, and recommendation and receipt of medications and vaccines during
each visit. Study subjects were college students 18 years or older who self-referred for a travel
consultation.
The PTC providers spent approximately 5 to 10 minutes per patient researching
destination risks prior to the visit and had a practice limited solely to pre-travel health. In
addition, the pharmacist providers had post-doctoral residency training that included travel
medicine and all possessed the Certificate of Knowledge in Travel Health® (CTH®) from the
International Society of Travel Medicine (ISTM). Visits in the pharmacist-run travel clinic are
structured to include thorough verbal counseling, printed patient education as well as provision
of necessary pre-travel medications and vaccines. In comparison, none of the PCPs had a
specialty practice or special training in travel medicine, nor were they required to complete such
training for their clinical practice. Pharmacists and PCPs had access to the same travel medicine
electronic resources.
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The decision to go to the PTC or a PCP was based on appointment availability and
scheduling preference of the student, and both the PTC and the PCPs had 30 minute
appointments. During the quality assurance process, vaccine and medication recommendations
were assessed for consistency with recommendations and guidelines from the Centers for
Disease Control and Prevention (CDC). Where CDC guidelines were unclear, the World Health
Organization and Travax® Encompass (Shoreland, Inc.) were consulted as secondary sources.
Medical and pharmacy records were queried to determine if students received recommended
medications and vaccines prior to travel. Prescriptions and vaccinations that were documented as
refused/declined by the patient were excluded from the analyses of receipt rates. All vaccines
were administered by nurses in the immunization clinic and all medications were dispensed from
the campus pharmacy. IRB approval was obtained prior to initiating the study.
Basic characteristics of the travelers and the frequencies (or the average numbers) of the
pre-travel recommendations between the PTC and the PCP groups were compared by using Chisquare test (or Fisher’s exact test) for categorical variables, and two sample T-test or WilcoxonMann-Whitney Test (Non-parametric version of independent samples T-test) for continuous
variables, if the normality assumptions underlying the T-test were violated. The primary
outcomes for vaccines and medications were 1) indicated and ordered, 2) indicated and not
ordered (excluding refused/declined), 3) not indicated and ordered, 4) and ordered and received
(excluding refused/declined). The univariate and multivariate logistic regressions (results not
shown in tables) were performed to help rate the findings according to their importance as
risk/protective factors. All variables that showed the association with the pre-travel
recommendations in the univariate models having P values below 0.10 were entered into the
more comprehensive multiple logistic regression models, which included visit type (PTC or
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PCP), trip duration, purposes of travel (for school activities and being volunteer), and destination
(Southeast Asia). All statistical significance was assessed using an alpha level of 0.05. Statistical
analysis was performed using SAS 9.2.+
Results
In 2007, 513 travelers were identified, 172 were seen by a PCP and 341 were seen in the
PTC. Travelers who were seen in the PTC were more often prescribed antibiotics for selftreatment of travelers’ diarrhea when indicated (96% vs. 50%, P < 0.0001), while travelers seen
by a PCP were more likely to be prescribed antibiotics not consistent with guidelines (not
ordered when indicated 49% vs 6%, P < 0.0001 and ordered when not indicated 21% vs. 3%, P <
0.0001) (Table 2). Furthermore, patients who were seen in the PTC were more likely to pick up
their medication from the pharmacy than those who were prescribed antibiotics by a PCP (75%
vs. 63%, P = 0.04). Travelers seen in the PTC were also more often prescribed antimalarials
when indicated (98% vs. 81%, P < 0.0001), while those seen by a PCP were more frequently
prescribed antimalarials not consistent with guidelines (not ordered when indicated 15% vs 1%,
P < 0.0001 and ordered when not indicated 19% vs. 2%, P < 0.0001). There was no statistically
significant difference in antimalarial pick-up rates from the pharmacy between the two groups
(Table 2).
Results regarding the ordering and receipt of vaccines were similar to those of antibiotics
and antimalarials. To account for multiple vaccines ordered at the same time, the number of
vaccines per patient was calculated and used for comparison purposes. Patients seen in the PTC
were ordered more vaccines per patient when indicated (mean = 2.77 vs 2.31, P = 0.0012), and
per patient were also more likely to receive vaccines when ordered (mean = 2.38 vs. 1.95, P =
0.0039). The PCPs recommended more vaccines that were not consistent with guidelines per
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patient (not ordered when indicated: mean = 0.78 vs 0.12, P < 0.0001, ordered when not
indicated: mean 0.18 vs. 0.025, P < 0.0001 (Table 3).
In addition to differences in recommendation and receipt of medications and
vaccinations, there were also some major differences in visit documentation among the PTC and
PCP groups. The pharmacist providers in the PTC group documented purpose of travel more
frequently than the PCPs (99% vs. 55%, P < 0.0001) and also documented activities planned by
the traveler more frequently (70% vs. 48%, P < 0.0001) than the PCPs.
There were no statistically significant differences between the two patient populations
except for destination and purpose of travel. The PTC saw more travelers to North Africa and
also more travelers with volunteer work as their purpose. The PCPs saw more travelers to North
and Southeast Asia and also more travelers with study abroad as their purpose. (Table 1).
Gender, age, and duration of travel were similar between the two groups.
The two categorical variables that demonstrated a clear statistically significant difference
in the multivariate analyses were visit type (PTC vs. PCP) and destination (travel to Southeast
Asia vs. others). When indicated, patients in the PTC and those seen by the PCP who were
traveling to Southeast Asia were more likely to be ordered the oral Typhoid vaccine (P = 0.0380,
OR = 1.743, 95% CI 1.031-2.945) and Tdap (P = 0.0045, OR = 2.204, 95% CI 1.277-3.802)
compared to other destinations. However, when indicated travelers who had a visit with a PCP
were less likely to be ordered the oral Typhoid vaccine (P = 0.0004, OR = 0.369, 95% CI 0.2110.643) and Tdap (P < 0.0001, OR = 0.224, 95% CI 0.127-0.395) compared to travelers who
visited the PTC. Trip duration and purpose of travel (volunteer and study abroad) did not have a
significant effect on whether or not the oral Typhoid vaccine and Tdap were ordered when
indicated. When ordered, travelers to Southeast Asia were also more likely to pick-up from the
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pharmacy azithromycin (P < 0.0001, OR = 7.375, 95% CI 3.353-16.22), atovaquone-proguanil
(P < 0.0024, OR = 2.33, 95% CI 1.351-4.02), oral Typhoid vaccine (P = 0.0398, OR = 1.749,
95% CI 1.027-2.981), and to receive Tdap vaccination (P = 0.0045, OR = 2.204, CI 1.2773.802).
Discussion
The results of this study support previous publications illustrating that recommendation
of medications and vaccines not consistent with guidelines is a potential problem for PCPs
without special training, demonstrating a need for additional education and training. 13, 18-19, 21-22
The most common area in which the PCPs failed to follow national/international guidelines was
in the omission of recommended antibiotics for the self-treatment of travelers’ diarrhea. The
PCPs only ordered an antibiotic for traveler’s diarrhea for half of the patients who were indicated
and less of their patients picked it from the pharmacy compared to the pharmacists. Since the
PTC visits are consistently structured to include extensive counseling on food/water precautions
and food/water borne illnesses, this may help explain why higher antibiotic pick-up rates
occurred among the PTC group. In both groups, pick-up rates for antibiotics were lower than for
antimalarials, suggesting that the study population may perceive food and water borne illnesses
as less serious than malaria.
Omission of recommendations for antimalarials and vaccines when indicated was also
common among PCPs. Purpose of travel and activities planned were only documented in half of
the PCP visits, suggesting that the providers either do not take these variables into consideration
or simply do not routinely document these patient specific factors. Practice guidelines suggest
taking into account these itinerary variables impacts the assessment of each patient’s indication
for medications and vaccines, and thus this may have affected PCP recommendations.
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The use of medications for travel to destinations where antimicrobial resistance exists,
such as ciprofloxacin for travelers’ diarrhea in Thailand or chloroquine for malaria
chemoprophylaxis in Africa, was another area where the PTC consistently showed higher
compliance with the national/international travel guidelines. Other areas of inconsistency
between PCP and PTC involved recommendations of vaccines for diseases where no risk exists,
such as Yellow Fever vaccine for a traveler to Southeast Asia.
The observations that the PTC saw more travelers with volunteer work as their primary
purpose and the PCPs saw more travelers with school as there primary purpose was expected.
The pharmacist-run travel clinic frequently conducts group consultations, which can be more
convenient for large, organized volunteer groups. Many study abroad programs require a
medical exam and clearance prior to a student enrolling, which would necessitate a traveler to
have a visit with a PCP. Since visits with the PTC and PCP were equal in length, vaccines were
administered in the same clinic, and medications were dispensed from the same pharmacy, these
factors should not have influenced outcomes. The PCPs generally had family medicine or
internal medicine training background and did receive a 1 hour travel medicine update every year
as part of a health center grand rounds program.
While previous studies of international community pharmacists have not been positive
toward their travel medicine knowledge, no such study has been conducted in the United States,
where all schools of pharmacy confer only the Doctor of Pharmacy degree after 6 to 8 years of
training and many graduates pursue post-graduate residencies. With the launch of the
Pharmacists Professional Group within the ISTM and more pharmacists sitting for the ISTM
CTH® exam, there are likely to be more trained and credentialed pharmacists to serve the
traveling public.
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Limitations
A limitation of the study is that the patient population consisted of young college students
and may not represent the general population. However, their destinations and itineraries mirror
populations in other reports. Additionally, appropriate use of vaccines and medications could
only be determined by the amount of information provided in the progress note; therefore, if a
recommendation was not documented it was assumed that it did not occur. Lastly, due to the
retrospective nature of the study, differences in post graduate training of the PCPs and the
volume of patients they saw could not be controlled.
Conclusion
A pharmacist-run pre-travel health clinic can provide more consistent evidence-based
care compared to primary care practitioners not specifically trained in travel medicine and may
improve patient compliance with recommendations. Pre-travel health is a dynamic and
specialized field that requires adequate time, resources, and expertise to deliver the best possible
care.
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Table 1: Traveler Characteristics
Gender
Male
Female
Age
18-25
26-35
36-45
46-55
>55
Duration of Travel¥
<1 week
>1, <2 weeks
>2, <4 weeks
>4, <12 weeks
> 12 weeks
Destinations+
Central America/Mexico/Caribbean
South America
North Africa* (P = 0.0418)
Sub-Saharan Africa
Middle East (Western Asia)
Western Europe
Eastern Europe
South Central Asia
Southeast & North Asia* (P = 0.0063)
Australia & New Zealand
Purpose of Travel¥ +
School* (P < 0.0001)
Business
Pleasure
Volunteer* (P < 0.0001)

PTC (N=341)

PCP (N=172)

124 (36.36%)
217 (63.64%)

61 (35.47%)
111 (65.53%)

259 (75.95%)
80 (23.46%)
1 (0.29%)
1 (0.29%)
0

124 (72.09%)
45 (26.16%)
2 (1.16%)
0
1 (0.58%)

53 (16.06%)
104 (31.52%)
64 (19.39%)
57 (17.27%)
52 (15.76%)

15 (9.87%)
53 (34.87%)
26 (17.11%)
27 (17.76%)
31 (20.39%)

148 (43.53%)
40 (11.76%)
13 (3.82%)
60 (17.65%)
3 (0.88%)
21 (6.18%)
9 (2.65%)
28 (8.24%)
73 (21.47%)
2 (0.59%)

60 (34.88%)
18 (10.47%)
1 (0.58%)
24 (13.95%)
4 (2.33%)
11 (6.40%)
6 (3.49%)
11 (6.40%)
56 (32.56%)
2 (1.16%)

85 (25.30%)
79 (23.51%)
10 (2.98%)
161 (47.92%)

51 (54.84%)
22 (24.18%)
1 (1.11%)
20 (22.47%)

* = Statistically Significant, + = Values do not add up to 100%, ¥ = Missing Data
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Table 2: Order and Receipt of Medications
PTC (N=341) PCP (N=172) P-Value*
Antibiotics
Ordered when indicated
327 (96.18%)
85 (50.30%)
<0.0001
#
Received when ordered
244 (74.62%)
51 (62.96%)
0.0359
Not Consistent with Guidelines
Not ordered when indicated
21 (6.16%)
84 (48.84%)
<0.0001
Ordered when not indicated
11 (3.25%)
22 (20.56%)
<0.0001
Antimalarials
Ordered when indicated
220 (97.78%) 111 (81.02%)
<0.0001
#
Received when ordered
176 (81.48%)
95 (86.36%)
0.2657
Not Consistent with Guidelines
Not ordered when indicated
5 (1.47%)
26 (15.12%)
<0.0001
Ordered when not indicated
5 (2.22%)
26 (18.98%)
<0.0001
# Medications documented as refused/declined were excluded from the analyses of receipt rates
* Chi-square test (or Fisher’s exact test) at 0.05 α level
Table 3: Order and Receipt of Vaccinations
PTC (N=341)
PCP (N=172)
Number of Vaccines Per
P-Value*
Patient
Mean
Median
std
Mean
Median
std
Ordered when indicated
2.78
3.00
1.49
2.06
2.00
1.34
<0.0001
#
Received when ordered
2.38
2.00
1.54
1.95
2.00
1.34
0.0039
Not Consistent with Guidelines
Not ordered when indicated
0.12
0
0.37
0.78
0
1.00
<0.0001
Ordered when not indicated
0.035
0
0.2
0.18
0
0.49
<0.0001
# Vaccinations documented as refused/declined were excluded from the analyses of receipt rates
* Wilcoxon-Mann-Whitney Test (Non-parametric version of independent samples T-test) at 0.05
α level

